Sinopharm
1099.HK
#2186
Rank
โ‚น778.35 B
Marketcap
โ‚น249.42
Share price
0.10%
Change (1 day)
20.86%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.500 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.500 Trillion. In 2024 the company made a revenue of โ‚น7.500 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.903 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.500 T-5.1%
2023โ‚น7.903 T5.42%
2022โ‚น7.497 T-2.1%
2021โ‚น7.657 T16.85%
2020โ‚น6.553 T14.95%
2019โ‚น5.701 T21.52%
2018โ‚น4.691 T5.93%
2017โ‚น4.428 T27.22%
2016โ‚น3.481 T5.37%
2015โ‚น3.303 T9.14%
2014โ‚น3.026 T17.22%
2013โ‚น2.582 T25.94%
2012โ‚น2.050 T34.61%
2011โ‚น1.523 T55.34%
2010โ‚น980.56 B35.79%
2009โ‚น722.12 B37.56%
2008โ‚น524.96 B31.43%
2007โ‚น399.43 B40.26%
2006โ‚น284.77 B